Loading clinical trials...
Loading clinical trials...
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa
Conditions
Interventions
SD-101-6.0 cream
Placebo (SD-101-0.0) cream
Locations
38
United States
Phoenix, Arizona, United States
Redwood City, California, United States
Aurora, Colorado, United States
Washington D.C., District of Columbia, United States
Miami, Florida, United States
Miami, Florida, United States
Start Date
March 11, 2015
Primary Completion Date
July 5, 2017
Completion Date
July 5, 2017
Last Updated
April 9, 2020
NCT06423573
NCT06330350
NCT05157958
NCT03526159
NCT07050810
NCT06330324
Lead Sponsor
Scioderm, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions